Treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates ischemic acute kidney injury

American Journal of Nephrology

Volumn 36, Issue 3, 2012, Pages 208-218

  Jamadarkhana, Prashant ^a   Chaudhary, Anita ^a   Chhipa, Laxmikant ^a   Dubey, Amita ^a   Mohanan, Anookh ^a   Gupta, Rameshchandra ^a   Deshpande, Shailesh ^a  

^a Torrent Pharmaceuticals Ltd   (India)

Author keywords

Acute kidney Injury; Hypoxia inducible factor; Postconditioning

Indexed keywords

CREATININE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGENASE INHIBITOR; TRC 160334; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; ISCHEMIC POSTCONDITIONING; KIDNEY ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN STABILITY; RAT; REPERFUSION INJURY; TREATMENT OUTCOME; URINE VOLUME;

ACUTE KIDNEY INJURY; ANIMALS; CELL LINE, TUMOR; CREATININE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GLYCINE; HETEROCYCLIC COMPOUNDS, 3-RING; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; PROCOLLAGEN-PROLINE DIOXYGENASE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TIME FACTORS;

EID: 84865601727     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000341870     Document Type: Article

References (30)

1. Lameire N, Van BW, Vanholder R: Acute renal failure. Lancet 2005; 365: 417-430.
2. Schofield CJ, Ratcliffe PJ: Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004; 5: 343-354.
3. Maxwell P: HIF-1: an oxygen response system with special relevance to the kidney. J Am Soc Nephrol 2003; 14: 2712-2722.
4. Bernhardt WM, Campean V, Kany S, Jurgensen JS, Weidemann A, Warnecke C, Arend M, Klaus S, Gunzler V, Amann K, Willam C, Wiesener MS, Eckardt KU: Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure. J Am Soc Nephrol 2006; 17: 1970-1978.
5. Masson N, Ratcliffe PJ: HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O 2 levels. J Cell Sci 2003; 116: 3041-3049.
6. Hill P, Shukla D, Tran MG, Aragones J, Cook HT, Carmeliet P, Maxwell PH: Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 2008; 19: 39-46.
7. Penna C, Mancardi D, Raimondo S, Geuna S, Pagliaro P: The paradigm of postconditioning to protect the heart. J Cell Mol Med 2008; 12: 435-458.
8. Yellon DM, Hausenloy DJ: Realizing the clinical potential of ischemic preconditioning and postconditioning. Nat Clin Pract Cardiovasc Med 2005; 2: 568-575.
9. Hausenloy DJ: Signalling pathways in ischaemic postconditioning. Thromb Haemost 2009; 101: 626-634.
10. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, Heusch G, Vinten-Johansen J, Yellon DM, Schulz R, Working Group of Cellular Biology of Heart of European Society of Cardiology: Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 2010; 87: 406-423.
11. Pagliaro P, Penna C: Cardiac postconditioning. Antioxid Redox Signal 2011; 14: 777-779.
12. Leconte C, Tixier E, Freret T, Toutain J, Saulnier R, Boulouard M, Roussel S, Schumann-Bard P, Bernaudin M: Delayed hypoxic postconditioning protects against cerebral ischemia in the mouse. Stroke 2009; 40: 3349-3355.
13. Szwarc I, Soullier S, Gayrard N, Mejean C, Mourad G, Argiles A: Ischemic postconditioning prevents ischemic acute renal failure. Transplant Proc 2007; 39: 2554-2556.
14. Chen H, Xing B, Liu X, Zhan B, Zhou J, Zhu H, Chen Z: Ischemic postconditioning inhibits apoptosis after renal ischemia/reperfusion injury in rat. Transplant Int 2008; 21: 364-371.
15. Serviddio G, Romano AD, Gesualdo L, Tamborra R, Di Palma AM, Rollo T, Altomare E, Vendemiale G: Postconditioning is an effective strategy to reduce renal ischaemia/reperfusion injury. Nephrol Dial Transplant 2008; 23: 1504-1512.
16. Yun Y, Duan WG, Chen P, Wu HX, Shen ZQ, Qian ZY, Wang DH: Down-regulation of cyclooxygenase-2 is involved in ischemic postconditioning protection against renal ischemia reperfusion injury in rats. Transplant Proc 2009; 41: 3585-3589.
17. Yun Y, Duan WG, Chen P, Wu HX, Shen ZQ, Qian ZY, Wang DH: Ischemic postconditioning modified renal oxidative stress and lipid peroxidation caused by ischemic reperfusion injury in rats. Transplant Proc 2009; 41: 3597-3602.
18. Eldaif SM, Deneve JA, Wang NP, Jiang R, Mosunjac M, Mutrie CJ, Guyton RA, Zhao ZQ, Vinten-Johansen J: Attenuation of renal ischemia-reperfusion injury by postconditioning involves adenosine receptor and protein kinase C activation. Transplant Int 2010; 23: 217-226.
19. Johnson DW, Pat B, Vesey DA, Guan Z, Endre Z, Gobe GC: Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney Int 2006; 69: 1806-1813.
20. Shah KG, Rajan D, Jacob A, Wu R, Krishnasastry K, Nicastro J, Molmenti EP, Coppa GF, Wang P: Attenuation of renal ischemia and reperfusion injury by human adrenomedullin and its binding protein. J Surg Res 2010; 163: 110-117.
21. Waikar SS, Liu KD, Chertow GM: Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol 2008; 3: 844-861.
22. Chatterjee PK, Zacharowski K, Cuzzocrea S, Otto M, Thiemermann C: Inhibitors of poly (ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo. FASEB J 2000; 14: 641-651.
23. Luna LG: Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology, ed 3. New York, McGraw-Hill, 1968.
24. Cruzado JM, Torras J, Riera M, Herrero I, Hueso M, espinosa l, Condom E, Lloberas N, Bover J, Alsina J, Grinyo JM: Influence of nephron mass in development of chronic renal failure after prolonged warm renal ischemia. Am J Physiol Renal Physiol 2000; 279:F259-F269.
25. Yun SP, Lee MY, Ryu JM, Song CH, Han HJ: Role of HIF-1alpha and VEGF in human mesenchymal stem cell proliferation by 17beta-estradiol: involvement of PKC, PI3K/Akt, and MAPKs. Am J Physiol Cell Physiol 2009; 296:C317-C326.
26. Rosenberger P, Schwab JM, Mirakaj V, Masekowsky E, Mager A, Morote-Garcia JC, Unertl K, Eltzschig HK: Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol 2009; 10: 195-202.
27. Hart ML, Grenz A, Gorzolla IC, Schittenhelm J, Dalton JH, Eltzschig HK: Hypoxiainducible factor-1 -dependent protection from intestinal ischemia/reperfusion injury involves ecto-5 -nucleotidase (CD73) and the A2B adenosine receptor. J Immunol 2011; 186: 4367-4374.
28. Weidemann A, Bernhardt WM, Klanke B, Daniel C, Buchholz B, Câmpean V, Amann K, Warnecke C, Wiesener MS, Eckardt KU, Willam C: HIF activation protects from acute kidney injury. J Am Soc Nephrol 2008; 19: 486-494.
29. Wang Z, Schley G, Türkoglu G, Burzlaff N, Amann KU, Willam C, Eckardt KU, Bernhardt WM: The protective effect of prolylhydroxylase inhibition against renal ischaemia requires application prior to ischaemia but is superior to EPO treatment. Nephrol Dial Transplant 2012; 27: 929-936.
30. Yeh CH, Hsu SP, Yang CC, Chien CT, Wang NP: Hypoxic preconditioning reinforces HIF-alpha-dependent HSP70 signaling to reduce ischemic renal failure-induced renal tubular apoptosis and autophagy. Life Sci 2010; 86: 115-123.